• Reference Citation Analysis
  • v
  • v
  • Find an Article
Find an Article PDF (4643497)   Today's Articles (66)   Subscriber (50551)
For: Bramness JG, Skurtveit S. Carisoprodol should be taken off the market. South Med J 2008;101:1074-5. [PMID: 18791514 DOI: 10.1097/SMJ.0b013e318184ac60] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
Number Cited by Other Article(s)
1
Plæhn G, Fuglsang T, Hindersson P, Breindahl T. Adverse effects from counterfeit and mislabeled medicine containing tapentadol and carisoprodol. Clin Case Rep 2024;12:e9241. [PMID: 39114837 PMCID: PMC11303665 DOI: 10.1002/ccr3.9241] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/07/2024] [Revised: 06/30/2024] [Accepted: 07/10/2024] [Indexed: 08/10/2024]  Open
2
Zacny JP, Paice JA, Coalson DW. Characterizing the subjective and psychomotor effects of carisoprodol in healthy volunteers. Pharmacol Biochem Behav 2011;100:138-43. [PMID: 21884720 DOI: 10.1016/j.pbb.2011.08.011] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/17/2011] [Revised: 08/02/2011] [Accepted: 08/12/2011] [Indexed: 11/28/2022]
PrevPage 1 of 1 1Next
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA